Celine Taglang, PhD

Title(s)Associate Specialist, Radiology
SchoolSchool of Medicine
Address1700 4th Street, #304
San Francisco CA 94158
ORCID ORCID Icon0000-0002-3927-6675 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California San Francisco, Department of Physical Therapy, San FranciscoPostdoctoral researchCurrentEvaluation of strategies to attenuate primary CNS lymphoma growth by testing promising agents
    University of California San Francisco, Department of Radiology and Biomedical Imaging, San FranciscoPostdoctoral research201913C labeling and hyperpolarization of biocompatible agents for MRI
    French Atomic Energy Commission - Paris Saclay University, Saclay, FrancePh.D in Organic Chemistry2015Enantiospecific C(sp3)-H activation catalyzed by ruthenium nanoparticles and isotopic labeling
    French Atomic Energy Commission - Paris Saclay University, Saclay, France2012Synthesis of chitosan NHC-N heterogeneous catalysts and study of their reactivity
    GlaxoSmithKline, Research Center, Les Ulis , Les Ulis, France2011Synthesis of anti-diabetic therapeutic molecules
    Sanofi, Medicinal Chemistry – Oncology, Vitry-sur-Seine, France2010Synthesis of kinase inhibitors
    Collapse Awards and Honors
    US Department of Defense Office of the Congressionally Directed Medical Research Programs2017  - 20192016 Prostate Cancer Research Program - Early Investigator Research Award
    French Atomic Energy Commission2012  - 2015IRTELIS-CEA PhD Program-Life Sciences Division

    Collapse Overview 
    Collapse Overview
    Post-doctoral researcher at UCSF, with a background in chemistry, working on 13C labeling and hyperpolarization of biocompatible agents for MRI with applications from enzymatic activity to animal models, my current research, in Chaumeil Lab, focuses on the evaluation of strategies to attenuate primary CNS lymphoma growth by testing promising agents with or without established therapies.

    I completed my PhD degree in 2015 at the Paris Saclay University, after three internships in organic and medicinal chemistry in two private companies (GSK, Sanofi) and one public institution (CEA). In the course of my trainings, I worked on the synthesis of anti-cancer and anti-diabetic therapeutic molecules and discovered my passion for Research in life sciences.

    During my PhD, my research focused on the enantiospecific C(sp3)-H activation followed by the deuterium incorporation onto stereogenic centers of small molecules. Using ruthenium nanoparticles, I applied this powerful and general method on 25 important chemical and biological compounds such as amines, aminoacids and small peptides. The mechanism of this fully stereoretentive process was investigated by a set of chemical experiments and DFT calculations which led to infer the reaction implied an unprecedented mechanism involving multiple ruthenium atoms and a σ-complex-assisted metathesis.

    After these diverse experiences, I decided to join Dr. Wilson's lab at UCSF: in hyperpolarized 13C MRI, one of the fundamental limitations is the effective lifetime of the signal, called T1. I developed a robust late stage deuteration methodology, which is broadly applicable to amino, and α-hydroxyl acids, like alanine and lactate. Incorporation of deuterium in these substrates led to a significant T1 prolongation, ranging from 16-29% at a position adjacent to the 13C nucleus. Moreover, when applied to directly attached 13C nuclei, this led to a greater than 4 fold increase in T1. Most importantly, when applied to in vivo imaging, [1-13C,2-2H]alanine demonstrated a greater than doubling of effective signal to noise ratio. I was also working with Dr. Flavell's lab on molecular strategies to image the acidic tumoral microenvironment. For example, [2-13C,D10]diethylmalonic acid is a strong potential candidate for high spatial resolution in vivo pH mapping. Instead of using a ratiometric method, it uses differences in chemical shifts and allows for the detection of multiple pH compartments within the same voxel in mice kidneys imaging experiments.

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Imaging telomerase reverse transcriptase expression in oligodendrogliomas using hyperpolarized δ-[1-13C]-gluconolactone. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad092. Batsios G, Taglang C, Gillespie AM, Viswanath P. PMID: 37600229; PMCID: PMC10433788.
      View in: PubMed   Mentions:
    2. Hyperpolarized δ-[1- 13C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma. Sci Rep. 2023 03 30; 13(1):5190. Minami N, Hong D, Taglang C, Batsios G, Gillespie AM, Viswanath P, Stevers N, Barger CJ, Costello JF, Ronen SM. PMID: 36997627; PMCID: PMC10063634.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer. Clin Cancer Res. 2022 08 15; 28(16):3526-3536. Batsios G, Taglang C, Tran M, Stevers N, Barger C, Gillespie AM, Ronen SM, Costello JF, Viswanath P. PMID: 35679032; PMCID: PMC9378519.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    4. Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas. Neuro Oncol. 2021 09 01; 23(9):1509-1522. Viswanath P, Batsios G, Ayyappan V, Taglang C, Gillespie AM, Larson PEZ, Luchman HA, Costello JF, Pieper RO, Ronen SM. PMID: 33864084; PMCID: PMC8408874.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    5. Imaging 6-Phosphogluconolactonase Activity in Brain Tumors In Vivo Using Hyperpolarized δ-[1-13C]gluconolactone. Front Oncol. 2021; 11:589570. Batsios G, Taglang C, Cao P, Gillespie AM, Najac C, Subramani E, Wilson DM, Flavell RR, Larson PEZ, Ronen SM, Viswanath P. PMID: 33937017; PMCID: PMC8082394.
      View in: PubMed   Mentions: 5  
    6. Imaging Brain Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy. Trends Neurosci. 2020 05; 43(5):343-354. Le Page LM, Guglielmetti C, Taglang C, Chaumeil MM. PMID: 32353337; PMCID: PMC7255622.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    7. Amino Acid-Derived Sensors for Specific Zn2+ Detection Using Hyperpolarized 13 C Magnetic Resonance Spectroscopy. Chemistry. 2019 Sep 12; 25(51):11842-11846. Wang S, Korenchan DE, Perez PM, Taglang C, Hayes TR, Sriram R, Bok R, Hong AS, Wu Y, Li H, Wang Z, Kurhanewicz J, Wilson DM, Flavell RR. PMID: 31338914; PMCID: PMC6742520.
      View in: PubMed   Mentions: 4     Fields:    
    8. Late-stage deuteration of 13C-enriched substrates for T1 prolongation in hyperpolarized 13C MRI. Chem Commun (Camb). 2018 May 17; 54(41):5233-5236. Taglang C, Korenchan DE, von Morze C, Yu J, Najac C, Wang S, Blecha JE, Subramaniam S, Bok R, VanBrocklin HF, Vigneron DB, Ronen SM, Sriram R, Kurhanewicz J, Wilson DM, Flavell RR. PMID: 29726563; PMCID: PMC6054790.
      View in: PubMed   Mentions: 16     Fields:    
    9. [11C]Para-Aminobenzoic Acid: A Positron Emission Tomography Tracer Targeting Bacteria-Specific Metabolism. ACS Infect Dis. 2018 07 13; 4(7):1067-1072. Mutch CA, Ordonez AA, Qin H, Parker M, Bambarger LE, Villanueva-Meyer JE, Blecha J, Carroll V, Taglang C, Flavell R, Sriram R, VanBrocklin H, Rosenberg O, Ohliger MA, Jain SK, Neumann KD, Wilson DM. PMID: 29712422; PMCID: PMC6045447.
      View in: PubMed   Mentions: 34     Fields:    Translation:Cells
    10. Ruthenium-catalyzed hydrogen isotope exchange of C(sp3)-H bonds directed by a sulfur atom. Chem Commun (Camb). 2018 Mar 25; 54(24):2986-2989. Gao L, Perato S, Garcia-Argote S, Taglang C, Martínez-Prieto LM, Chollet C, Buisson DA, Dauvois V, Lesot P, Chaudret B, Rousseau B, Feuillastre S, Pieters G. PMID: 29505052.
      View in: PubMed   Mentions: 10     Fields:    
    11. Dicarboxylic acids as pH sensors for hyperpolarized 13C magnetic resonance spectroscopic imaging. Analyst. 2017 May 02; 142(9):1429-1433. Korenchan DE, Taglang C, von Morze C, Blecha JE, Gordon JW, Sriram R, Larson PEZ, Vigneron DB, VanBrocklin HF, Kurhanewicz J, Wilson DM, Flavell RR. PMID: 28322385; PMCID: PMC5462110.
      View in: PubMed   Mentions: 12     Fields:    
    12. Enantiospecific C-H Activation Using Ruthenium Nanocatalysts. Angew Chem Int Ed Engl. 2015 Sep 01; 54(36):10474-7. Taglang C, Martínez-Prieto LM, del Rosal I, Maron L, Poteau R, Philippot K, Chaudret B, Perato S, Sam Lone A, Puente C, Dugave C, Rousseau B, Pieters G. PMID: 26371960.
      View in: PubMed   Mentions: 28     Fields:    
    13. Regioselective and stereospecific deuteration of bioactive aza compounds by the use of ruthenium nanoparticles. Angew Chem Int Ed Engl. 2014 Jan 03; 53(1):230-4. Pieters G, Taglang C, Bonnefille E, Gutmann T, Puente C, Berthet JC, Dugave C, Chaudret B, Rousseau B. PMID: 24254536.
      View in: PubMed   Mentions: 23     Fields:    Translation:Cells
    Celine's Networks
    Concepts (38)
    Derived automatically from this person's publications.
    Co-Authors (20)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department